|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Esophageal Cancer | |||||
| Gastric Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Adenocarcinoma | |||||
| Esophageal Diseases | |||||
| Esophageal Neoplasms | |||||
| Stomach Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Head and Neck Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Stomach Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| ixabepilone | |||||
| 5 | Sponsors listed in this trial | ||||
| Memorial Sloan-Kettering Cancer Center | |||||
| National Cancer Institute (NCI) | |||||